Improved Discrimination Of Central And Obstructive Apnoeas In Infants
Launched by SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST · Jan 15, 2020
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • •Infants between 36 weeks post conception and one year old referred to the respiratory and sleep team for central or obstructive apnoea or apparent life threatening events.
- Exclusion Criteria:
- • •Chest wall deformity on injury that precludes the use of the Volusense paediatric device.
About Sheffield Children's Nhs Foundation Trust
Sheffield Children's NHS Foundation Trust is a leading pediatric healthcare institution in the UK, dedicated to providing exceptional clinical care and advancing medical research for children. With a strong commitment to improving health outcomes, the Trust conducts innovative clinical trials that aim to enhance treatment options and care practices for pediatric patients. By collaborating with a multidisciplinary team of healthcare professionals and researchers, Sheffield Children's NHS Foundation Trust is at the forefront of child health research, contributing valuable insights to the global medical community while ensuring the highest standards of safety and ethics in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sheffield, Sheffield (South Yorkshire District), United Kingdom
Patients applied
Trial Officials
Kelechi Ugonna
Principal Investigator
Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials